@FierceMedDev: Congress considering bill to limit FDA regulation of EHRs, clinical decision support software. Story | Follow @FierceMedDev
@VarunSaxena2: RT @FierceMedDev: From FierceDrugDelivery: Survey raises the question: Do patients really know how to use drug delivery devices? Story | Follow @VarunSaxena2
@EmilyWFierce: ICYMI: LabCorp and CareDx call it quits on partnership to develop lupus test. FierceDiagnostics story | Follow @EmilyWFierce
> Innovative Cardiovascular Solutions raised $5 million towards its Emblok Embolic Protection Catheter for heart interventional procedures. Release
> The Pentagon is working on development of a "care cube" that will act as a protective bubble allowing medics to assist Ebola patients with lower risk of infection. Story
> Ireland's Neuromod Devices received a CE mark for Mutebutton, its multi-sensory medical device used to treat tinnitus. Read
> Device developer Creo Medical closed a £3.5 million ($5.5 million) funding round to use towards continuing development of the CROMA platform, an electrosurgical system. Release
Biotech News
@FierceBiotech: Woodford's investment strategy may help change the global biotech scene. Editor's Corner | Follow @FierceBiotech
@JohnCFierce: Fledgling biotech upstart blends cutting-edge cancer immunotherapy strategies -- BeneVir. Article | Follow @JohnCFierce
@DamianFierce: It's almost as if Italian authorities don't care about biotech traders. More | Follow @DamianFierce
> Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown. News
> Biotech's Boston blitz is making lab space harder--and costlier--to come by. Story
> Novartis cans a researcher whose cooked data led to a slew of retractions. More
Pharma News
@FiercePharma: Merck KGaA to power India plant with coconut and cashew shells. Story | Follow @FiercePharma
@CarlyHFierce: AstraZeneca's Almirall buy yields its first new drug--and now, AZ has to sell it. More | Follow @CarlyHFierce
> Who are the stars of personalized meds? Roche, Novartis and J&J. More
> Sanofi's pre-game show on Afrezza has MannKind followers chattering. Item
> Odds for a Pfizer-AZ matchup? All over the map, if you listen to analysts. Article
Drug Delivery News
> RNAi specialist Arrowhead reports loss of $58.7M in FY 2014. Item
> Singapore team combines cancer drugs, diagnostics in one biomarker nanoparticle. Report
> 'Hybrid' delivery vehicle gives DNA vaccines new potential. News
> Survey raises the question: Do patients really know how to use drug delivery devices? More
> Patients respond positively to Cynapsus film strip of apomorphine to combat Parkinson's. Article
Diagnostics News
> Curetis nabs $18M to support European Dx rollout, U.S. trial, possible IPO. News
> Illumina and bioMérieux to develop innovative sequencing system for infectious diseases. Article
> Indian startup develops low-cost, portable Dx for developing countries. Story
> LabCorp and CareDx call it quits on partnership to develop lupus test. Report
> Illumina teams up with Broad Institute, USAID for Ebola tracking. Item
Pharma Marketing News
> Who are the stars of personalized medicine? Roche, Novartis and J&J. Article
> From GPS inhalers to Jawbone data-gathering, some digital pharma inspiration. Story
> MannKind fans and critics line up for Sanofi's Afrezza pre-game show. More
> Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push. Story
> AstraZeneca's Almirall buy yields its first new drug--and now, AZ has to sell it. Article